ANALYST RECOMMENDATIONS : Activision Blizzard, AstraZeneca, Citigroup, Microsoft, Model N...

Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Activision Blizzard: Stifel downgrades to hold from buy. PT up 4.4% to $95.
• AstraZeneca: UBS upgrades from Neutral to Buy. The target price is revised upwards from GBp 13000 to GBp 12500.
• Citigroup: Societe Generale downgrades Citigroup to Hold from Buy, adjusts PT to $50 from $67
• Integra LifeSciences: Jefferies upgrades to buy from hold. PT up 28% to $53.
• international Consolidated Airlines: Deutsche Bank downgrades to Neutral. Previously set at GBp 200, the target price is lowered to GBp 165.
• Jack Henry: Goldman Sachs initiated coverage with a recommendation of neutral. PT up 5% to $173.
• Jefferies: Morgan Stanley upgrades to equal-weight from underweight. PT up 7.1% to $36.
• Lazard: Morgan Stanley upgrades to overweight from equal-weight. PT up 31% to $43.
• Marsh & McLennan: Baptista Research  initiated coverage with a recommendation of hold. PT set to $199.
• Microsoft: Guotai Junan Securities initiated coverage with a recommendation of overweight. PT set to $384.80.
• Model N: Jefferies initiated coverage with a recommendation of hold. PT set to $40.
• Sealed Air: Baird upgrades to outperform from neutral. PT up 14% to $49.